Curis Inc
1 known investors
Curis is a biopharmaceutical company developing therapeutics for cancer treatment, with a pipeline targeting hematologic malignancies and other cancers through drug candidates such as its lead IRAK4 inhibitor. Its programs span leukemia, lymphoma, and immune checkpoint inhibitor targets.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Curis Inc do?
- Curis is a biopharmaceutical company developing therapeutics for cancer treatment, with a pipeline targeting hematologic malignancies and other cancers through drug candidates such as its lead IRAK4 inhibitor. Its programs span leukemia, lymphoma, and immune checkpoint inhibitor targets.
- Who are Curis Inc's investors?
- Curis Inc's investors include HEALTHCARE ROYALTY PARTNERS.